BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/6/2015 1:18:00 PM | Browse: 998 | Download: 1367
 |
Received |
|
2015-03-29 13:14 |
 |
Peer-Review Started |
|
2015-03-29 15:11 |
 |
To Make the First Decision |
|
2015-04-24 19:23 |
 |
Return for Revision |
|
2015-07-02 21:10 |
 |
Revised |
|
2015-07-04 15:23 |
 |
Second Decision |
|
2015-08-21 13:12 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2015-09-15 14:28 |
 |
Articles in Press |
|
2015-09-15 14:28 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2015-10-07 23:50 |
 |
Typeset the Manuscript |
|
2015-11-04 16:27 |
 |
Publish the Manuscript Online |
|
2015-12-06 13:18 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Basic Study |
Article Title |
Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yun Shi, Si-Ye Wang, Min Yao, Wen-Li Sai, Wei Wu, Jun-Ling Yang, Yin Cai, Wen-Jie Zheng and Deng-Fu Yao |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Jiangsu Provincial Special Programs of Medical Science |
BL2012053 |
Jiangsu Provincial Special Programs of Medical Science |
HK201102 |
Nantong Undertaking and Technological Innovation |
HS2013007 |
Nantong Undertaking and Technological Innovation |
BK2013048 |
Nantong Undertaking and Technological Innovation |
HS2014078 |
riority Academic Program Development of Higher Education Institution of Jiangsu Province, the National Natural Science Foundation |
81200634 |
international S &T Cooperation Program of China |
2013DFA32150 |
|
Corresponding Author |
Deng-Fu Yao, MD, PhD, Professor, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, No. 20 West Temple Road, Nantong 226001, Jiangsu Province, China. yaodf@ahnmc.com |
Key Words |
Hepatocellular carcinoma; Nuclear factor-κB; Multidrug-resistant; Chemosensitization; Small interference RNA; P-glycoprotein |
Core Tip |
Hepatic nuclear factor-kappa B (NF-κB) signaling pathway could be a potential target for designing highly effective therapeutic agents for the chemoprevention of hepatocellular carcinoma (HCC). Specific siRNAs used in combination with doxorubicin could enhance doxorubicin cytotoxicity in human HepG2 cells by downregulating NF-κB and P-glycoprotein expression. Stable NF-κB inhibition and chemosensitization could significantly inhibit tumor cell proliferation. Thus, the modulation of NF-κB might represent an advance in HCC therapy efficacy and is worthy of further research and investigation.
|
Publish Date |
2015-12-06 13:18 |
Citation |
Shi Y, Wang SY, Yao M, Sai WL, Wu W, Yang JL, Cai Y, Zheng WJ, Yao DF. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. World J Gastroenterol 2015; 21(45): 12814-12821 |
URL |
http://www.wjgnet.com/1007-9327/full/v21/i45/12814.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v21.i45.12814 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345